CF Lung Infection Therapy AR-501 Granted FDA Orphan Drug Status

CF Lung Infection Therapy AR-501 Granted FDA Orphan Drug Status

FDA Grants Orphan Drug Status to AR-501, Potential CF Treatment for Chronic Lung Infections

 JULY 1, 2019

BY ANA PENA

 

IN NEWS.